Advanced Search

 

Study ID Status Title Patient Level Data
112708 Completed Control of Asthma With Addition of Long-Acting Beta-Agonists to Inhaled Corticosteroid Regimens Systematic Review A Meta-analysis of Observational Studies
112720 Completed Special Drug Use Investigation for Imigran STAT
112721 Completed Special Drug Use Investigation for ARIXTRA (fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)
112721 Completed Special Drug Use Investigation for ARIXTRA (fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)
112727 Completed Drug Use Investigation for LAMICTAL
112727 Completed Drug Use Investigation for LAMICTAL
112728 Completed Special Drug Use Investigation for LAMICTAL (Long term)
112745 Completed Safety and immunogenicity study of GSK Biologicals’ Plasmodium falciparum malaria vaccine 257049 administered to HIV infected infants and children Study Listed on ClinicalStudyDataRequest.com
112752 Completed Zen study – Patients from the NADIS database treated with abacavir (Ziagen®), clinical and virologic data.
112753 Completed A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112754 Completed A randomized, open-label, parallel-group, multicenter study to determine the efficacy and long-term safety of albiglutide compared with insulin in subjects with type 2 diabetes mellitus. Study Listed on ClinicalStudyDataRequest.com
112755 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Pioglitazone With or Without Metformin in Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112756 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112757 Completed A Randomized, Double-blind, Placebo and Active-Controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and with Metformin plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112758 Completed A phase I/II, a single arm, open-label study of ofatumumab (GSK1841157) in patients with previously treated chronic lymphocytic leukemia
112760 Completed An Observational Study To Assess The Burden Of Illness In Prostate Cancer Patients With Low To Moderate Risk Of Progression
112765 Completed A Randomized, Blinded, Placebo-controlled, Two-Phase, Sequential Cohort, Dose Finding Study to Assess the Safety and Efficacy of an Oral Thrombopoietin Receptor Agonist, Eltrombopag (SB-497115-GR), Administered to Patients with Solid Tumors Receiving Gemcitabine monotherapy or the combination of Gemcitabine Plus Carboplatin or Cisplatin
112771 Completed An open label study conducted in healthy subjects to demonstrate bioequivalence between ropinirole prolonged release tablets (ropinirole XL, marketed as REQUIP-MODUTAB™, REQUIP XL™ at 2 mg) manufactured at Crawley and Aranda Study Listed on ClinicalStudyDataRequest.com
112772 Completed Follow-up study to evaluate the long-term immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV (580299) vaccine in healthy female subjects Study Listed on ClinicalStudyDataRequest.com
112773 Completed An open label positron emission tomography study in healthy male subjects to investigate brain DAT and SERT occupancy, pharmacokinetics and safety of single oral doses ofGSK1360707, using 11C- PE2I and 11C-DASB as PET ligands Study Listed on ClinicalStudyDataRequest.com
112776 Completed A randomized, double-blind, placebo-controlled, two-way crossover 7-day study to investigate the safety, tolerability, pharmacodynamics and pharmacokinetics of repeat dose inhaled GW642444 25 μg (micrograms) in children aged 5-11 years with persistent asthma. Study Listed on ClinicalStudyDataRequest.com
112777 Completed A randomized, double-blind, repeat dose, two period crossover study to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of inhaled fluticasone furoate/vilanterol 100/25 micrograms in children aged 5 to 11 years with persistent asthma Study Listed on ClinicalStudyDataRequest.com
112784 Completed General characteristics of chronic hepatitis B(CHB) patients in Korea
112789 Completed Drug Use Investigation for Zofran Syrup
112791 Completed SCOT Registry: Small Cell Lung Cancer Treatment and Outcome

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.